![]() ![]() | Massenet, T., Potjewijd, J., Tobal, R., GESTER, F., Zanella, D., Henket, M., Njock, M.-S., Dejong, T., Gridelet, G., GILTAY, L., GUISSARD, F., André, B., Ribbens, C., Louis, R., Van Paassen, P., Guiot, J., & Stefanuto, P.-H. (November 2024). Systemic Sclerosis: Can Breathomics help clinicians for ILD management? [Poster presentation]. Breath Biopsy Conference 2024. |
![]() ![]() | Massenet, T., Patjewijd, J., Tobal, R., GESTER, F., Zanella, D., Henket, M., Njock, M.-S., Dejong, T., Gridelet, G., GILTAY, L., GUISSARD, F., André, B., Ribbens, C., Louis, R., Van Paassen, P., Guiot, J.* , & Stefanuto, P.-H.*. (08 September 2024). SYSTEMIC SCLEROSIS: CAN BREATHOMICS MONITOR INTERSTITIAL LUNG DISEASE? [Poster presentation]. The ERS Congress, Vienne, Austria. * These authors have contributed equally to this work. |
![]() ![]() | Massenet, T., Potjewijd, J., Tobal, R., GESTER, F., Zanella, D., Henket, M., Njock, M.-S., Dejong, T., Gridelet, G., GILTAY, L., GUISSARD, F., André, B., Ribbens, C., Louis, R., Van Paassen, P., Focant, J.-F., Guiot, J., & Stefanuto, P.-H. (28 May 2024). Tackling the analytical challenges to establish a routine workflow for breathomics research [Paper presentation]. 18th International Symposium on Hyphenated Techniques in Chromatography and Separation Technology (HTC-18), Leuven, Belgium. |
![]() ![]() | Peters, C.* , Malaise, O.* , Longton, J., André, B., & Ribbens, C. (December 2023). Vignette thérapeutique de l’étudiant. Prise en charge de la goutte. Revue Médicale de Liège, 78 (12), 733 - 739. ![]() * These authors have contributed equally to this work. |
![]() ![]() | JACQUERIE, P., André, B., de Seny, D., Henket, M., GILTAY, L., Ernst, M., Louis, R., Malaise, M., Ribbens, C., & Guiot, J. (03 November 2023). Reproducibility of pulmonary function tests in patients with systemic sclerosis. Scientific Reports, 13 (1), 18960. doi:10.1038/s41598-023-45881-y ![]() |
![]() ![]() | Massenet, T., Potjewijd, J., Henket, M., Gridelet, G., Zanella, D., Dejong, T., GILTAY, L., GESTER, F., GUISSARD, F., André, B., Ribbens, C., Van Paassen, P., Louis, R., Focant, J.-F., Guiot, J.* , & Stefanuto, P.-H.*. (20 June 2023). Breath analysis to diagnose and assess systemic sclerosis using thermal desorption and comprehensive two-dimensional gas chromatography high-resolution time-of-flight mass spectrometry [Poster presentation]. Metabolomics 2023, Niagara Falls, Canada. * These authors have contributed equally to this work. |
![]() ![]() | Massenet, T., Guiot, J., Zanella, D., Dejong, T., GILTAY, L., Henket, M., GUISSARD, F., André, B., Malaise, M., Potjewijd Judith, Schleich, F., Louis, R., Focant, J.-F., & Stefanuto, P.-H. (29 March 2023). Etude métabolomique de l’air exhalé pour diagnostiquer la sclérodermie systémique par chromatographie gazeuse bidimensionnelle exhaustive [Paper presentation]. SEP 23, Paris, France. |
Stefanuto, P.-H., Zanella, D., Dejong, T., Massenet, T., Di giovanni, N., GILTAY, L., Henket, M., GUISSARD, F., Schleich, F., Guiot, J., André, B., Malaise, M., Potjewijd, J., Meuwis, M.-A., Louis, E., Louis, R., & Focant, J.-F. (2023). A Journey over Current Usage of GC×GC -TOFMS in Metabolomic [Paper presentation]. GCxGC & GCTOF metabonomics Webinar. |
![]() ![]() | Massenet, T., GUIOT, J., Zanella, D., Dejong, T., GILTAY, L., HENKET, M., GUISSARD, F., ANDRE, B., MALAISE, M., Judith Potjewijd, SCHLEICH, F., LOUIS, R., Focant, J.-F., & Stefanuto, P.-H. (18 May 2022). BREATHOMICS APPROACH TO INVESTIGATE SYSTEMIC SCLEROSIS USING THERMAL DESORPTION AND COMPREHENSIVE TWO-DIMENSIONAL GAS CHROMATOGRAPHY HIGH-RESOLUTION TIME-OF-FLIGHT MASS SPECTROMETRY [Poster presentation]. 17th International Symposium on Hyphenated Techniques in Chromatography and Separation Technology (HTC-17), Gand, Belgium. |
![]() ![]() | Stefanuto, P.-H., Zanella, D., Dejong, T., Massenet, T., DiGiovanni, N., GILTAY, L., HENKET, M., GUISSARD, F., SCHLEICH, F., GUIOT, J., ANDRE, B., MALAISE, M., Potjewijd, J., MEUWIS, M.-A., LOUIS, E., & Focant, J.-F. (May 2022). Recent advances in medical applications of GC×GC [Paper presentation]. HTC-17, Ghent, Belgium. ![]() |
![]() ![]() | Massenet, T., GUIOT, J., Zanella, D., Dejong, T., GILTAY, L., HENKET, M., GUISSARD, F., ANDRE, B., MALAISE, M., Potjewijd Judith, SCHLEICH, F., LOUIS, R., Focant, J.-F., & Stefanuto, P.-H. (01 February 2022). TD-GC×GC-HRTOFMS to investigate pulmonary fibrosis in patients [Poster presentation]. Multidimensional Chromatography Worshop 2022. |
Focant, J.-F., Stefanuto, P.-H., Zanella, D., Dejong, T., Massenet, T., Di Giovanni, N., GILTAY, L., Henket, M., GUISSARD, F., Schleich, F., Guiot, J., André, B., Malaise, M., Potjewijd, J., Meuwis, M.-A., Louis, E., & Louis, R. (2022). Exploring Volatolomes with GC×GC-TOFMS [Paper presentation]. Analytics Nantes 2022, Nantes, France. ![]() |
![]() ![]() | Zanella, D., GUIOT, J., Stefanuto, P.-H., GILTAY, L., HENKET, M., GUISSARD, F., ANDRE, B., MALAISE, M., Pojtewijd, J., SCHLEICH, F., Louis, R., & Focant, J.-F. (2021). Breathomics to diagnose systemic sclerosis using thermal desorption and comprehensive two-dimensional gas chromatography high-resolution time-of-flight mass spectrometry. Analytical and Bioanalytical Chemistry. doi:10.1007/s00216-021-03333-4 ![]() |
![]() ![]() | Gendebien, Z., VON FRENCKELL, C., RIBBENS, C., ANDRE, B., THYS, M., GANGOLF, M., SEIDEL, L., MALAISE, M., & MALAISE, O. (March 2021). Systematic analysis of Covid-19 infection and symptoms in a systemic lupus erythematous population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments [Paper presentation]. Belgian congress of rheumatology 2021. ![]() |
![]() ![]() | Zanella, D., GUIOT, J., Stefanuto, P.-H., GILTAY, L., HENKET, M., GUISSARD, F., ANDRE, B., MALAISE, M., Potjewijd, J., SCHLEICH, F., LOUIS, R., & Focant, J.-F. (2021). TD-GC×GC-HRTOFMS for Breath Profiling of Systemic Sclerosis. In Proceedings. ![]() |
![]() ![]() | GUIOT, J., NJOCK, M.-S., ANDRE, B., GESTER, F., HENKET, M., DE SENY, D., MOERMANS, C., MALAISE, M., & LOUIS, R. (2021). Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction. Scientific Reports, 11 (1), 10882. doi:10.1038/s41598-021-90333-0 ![]() |
![]() ![]() | Gendebien, Z., VON FRENCKELL, C., RIBBENS, C., ANDRE, B., THYS, M., GANGOLF, M., SEIDEL, L., Malaise, M., & MALAISE, O. (2020). Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments. Annals of the Rheumatic Diseases. doi:10.1136/annrheumdis-2020-218244 ![]() |
![]() ![]() | Guiot, J., HENKET, M., André, B., Herzog, M., Hardat, N., NJOCK, M.-S., MOERMANS, C., Malaise, M., & Louis, R. (2020). A new nucleosomic-based model to identify and diagnose SSc-ILD. Clinical Epigenetics, 12 (1), 124. doi:10.1186/s13148-020-00915-4 ![]() |
![]() ![]() | BONHOMME, O., ANDRE, B., GESTER, F., DE SENY, D., MOERMANS, C., Struman, I., Louis, R., MALAISE, M., & GUIOT, J. (2019). Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature. Rheumatology. doi:10.1093/rheumatology/kez230 ![]() |
![]() ![]() | Voilliot, D., Magne, J., DULGHERU, R. E., Kou, S., Henri, C., Caballero, L., De Sousa, C., SPRYNGER, M., ANDRE, B., Pierard, L., & LANCELLOTTI, P. (2015). Cardiovascular outcome in systemic sclerosis. Acta Cardiologica, 70 (5), 554-63. doi:10.2143/AC.70.5.3110516 ![]() |
![]() ![]() | COLLIN, R., ANDRE, B., Crielaard, J.-M., & Kaux, J.-F. (December 2014). Calcifications des tissus mous des jambes. Revue Médicale de Liège, 69 (12), 641-643. ![]() |
![]() ![]() | MALAISE, O., VON FRENCKELL, C., ANDRE, B., & Malaise, M. (28 August 2013). The management of systemic lupus erythematosus with biological therapies. Revue Médicale Suisse, 9 (395), 1507-11. ![]() |
![]() ![]() | MALAISE, O., VON FRENCKELL, C., ANDRE, B., & MALAISE, M. (August 2013). The management of systemic lupus erythematosus with biological therapies. Revue Médicale de Liège, 28 (9(395)), 1507-11. ![]() |
![]() ![]() | DELANAYE, P., BOUQUEGNEAU, A., DUBOIS, B., & ANDRE, B. (2012). Le médicament du mois : Fébuxostat (Adenuric®). Revue Médicale de Liège, 67 (4), 202-209. |
![]() ![]() | Beckers, C., Jeukens, X., Ribbens, C., Andre, B., Marcelis, S., Leclercq, P., Kaiser, M.-J., Willems, J., Hustinx, R., & Malaise, M. (March 2006). F-18-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. European Journal of Nuclear Medicine and Molecular Imaging, 33 (3), 275-280. doi:10.1007/s00259-005-1952-3 ![]() |
![]() ![]() | Beckers, C., Ribbens, C., Andre, B., Marcelis, S., Kaye, O., Mathy, L., KAISER, M.-J., Hustinx, R., Willems, J., & Malaise, M. (June 2004). Assessment of disease activity in rheumatoid arthritis with 18F-FDG PET. Journal of Nuclear Medicine, 45 (6), 956-964. ![]() |
![]() ![]() | Ribbens, C., Andre, B., Marcelis, S., Kaye, O., Mathy, L., Bonnet, V., Beckers, C., & Malaise, M. (2003). Rheumatoid hand joint synovitis: gray-scale and power Doppler US quantifications following anti-tumor necrosis factor-alpha treatment: pilot study. Radiology, 229 (2), 562-569. doi:10.1148/radiol.2292020206 ![]() |
![]() ![]() | BECKERS, C., RIBBENS, C., ANDRE, B., MARCELLIS, M., KAYE, O., RIGO, P., HUSTINX, R., FOIDART-WILLEMS, J., & MALAISE, M. (2002). FDG-PET imaging for monitoring rheumatoid arthritis treated by infliximab injections. Journal of Nuclear Medicine, 43, 38. ![]() |
![]() ![]() | BECKERS, C., RIBBENS, C., ANDRE, B., MARCELLIS, M., KAYE, O., RIGO, P., HUSTINX, R., FOIDART-WILLEMS, J., & MALAISE, M. (2002). Characterization of inflamed joints in rheumatoid arthritis patients using FDG-PET: correlation with clinical and ultrasonographical assessment. Journal of Nuclear Medicine, 43, 38. ![]() |
![]() ![]() | Ribbens, C., Andre, B., Kaye, O., & Malaise, M. (2001). Actualités thérapeutiques de la polyarthrite rhumatoïde. Revue de la Médecine Générale, 186, 372-376. ![]() |
![]() ![]() | Ribbens, C., Andre, B., Jaspar, J. M., Kaye, O., Kaiser, M.-J., De Groote, D., & Malaise, M. (2000). Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis. Journal of Rheumatology, 120 (1), 888-893. ![]() |
![]() ![]() | Ribbens, C., Andre, B., Kaye, O., Kaiser, M. J., Bonnet, V., de Groote, D., Franchimont, N., & Malaise, M. (2000). Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies. European Cytokine Network, 11 (4), 669-676. ![]() |
![]() ![]() | Ribbens, C., Bonnet, V., Kaiser, M.-J., Andre, B., Kaye, O., Franchimont, N., De Groote, D., Beguin, Y., & Malaise, M. (2000). Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA). Clinical and Experimental Immunology, 120 (1), 194-199. doi:10.1046/j.1365-2249.2000.01198.x ![]() |
![]() ![]() | Ribbens, C., Andre, B., Kaye, O., Kaiser, M. J., Bonnet, V., Jaspar, J. M., de Groote, D., Franchimont, N., & Malaise, M. (2000). Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not. Rheumatology, 39 (12), 1357-1365. doi:10.1093/rheumatology/39.12.1357 ![]() |
![]() ![]() | Andre, B., Ribbens, C., Kaye, O., & Malaise, M. (April 1997). Les manifestations osteo-articulaires du sujet âgé. Revue Médicale de Liège, 52 (4), 270-277. ![]() |
![]() ![]() | Andre, B., Ribbens, C., Kaye, O., & Malaise, M. (1997). Ciclosporine et maladies systémiques. Médecine et Hygiène, 55, 1510-1514. ![]() |
![]() ![]() | Leprince, P., Rogister, B., Delree, P., Rigo, J.-M., Andre, B., & Moonen, G. (August 1991). Modulation of Proteolytic Activity During Neuritogenesis in the Pc12 Nerve Cell: Differential Control of Plasminogen Activator and Plasminogen Activator Inhibitor Activities by Nerve Growth Factor and Dibutyryl-Cyclic Amp. Journal of Neurochemistry, 57 (2), 665-74. doi:10.1111/j.1471-4159.1991.tb03798.x ![]() |